title: [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome].
abstract: Vogt-Koyanagi-Harada syndrome is an autoimmune multisystem disease, characterized by the association of ocular inflammatory manifestations (uveitis and retinal detachment) and extraocular lesions such as meningismus and tegumentary or auditory findings. We report the case of a Hispanic woman with this syndrome.
authors.affiliation: Servicio de Otorrinolaringología, Hospital Universitario La Fe, Valencia, España. pecasve@hotmail.com
authors.forename: Verónica
authors.initials: V
authors.lastname: Rodríguez Rivera
authors.forename: Herminio Pérez
authors.initials: HP
authors.lastname: Garrigues
authors.forename: Roberto
authors.initials: R
authors.lastname: Gallego Pinazo
mesh_terms: D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use; D001299:Audiometry; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006312:Hearing Loss, Bilateral / Q000209:etiology / Q000503:physiopathology*; D006319:Hearing Loss, Sensorineural / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D014607:Uveomeningoencephalitic Syndrome / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068879:Adalimumab; D011241:Prednisone; D008775:Methylprednisolone; D008727:Methotrexate